Harrow, Inc.

HROW · Healthcare

$36.97

Capitalizzazione: 1.39B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Harrow, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

Insider Monkey3 set 2026, 14:44

This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks

GlobeNewswire1 set 2026, 11:00

Harrow to Participate in Three Investor Conferences in September

Insider Monkey20 ago 2026, 12:24

Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target

MT Newswires20 ago 2026, 11:46

Harrow's IHEEZO Cuts Patient-Reported Discomfort 58% in Intravitreal-Injection Study

GlobeNewswire20 ago 2026, 11:00

Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections